Audio: US to resume J&J COVID vaccinations despite rare clot risk
Updated:
MAIN AREA TOP drop zone ⇩
MAIN AREA TOP drop zone ⇩
maylen
AUTO TEST CUSTOM HTML 20241114185800
AUTO TEST CUSTOM HTML 20241115200405
AUTO TEST CUSTOM HTML 20241118165728
AUTO TEST CUSTOM HTML 20241118184948
WASHINGTON (NewsNation Now) — U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot.
Site Settings Survey
MAIN AREA MIDDLE drop zone ⇩